PDEX logo
NASDAQ · PDEXMedical - Instruments & SuppliesUpdated Nov 4, 2026

Pro-Dex, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Pro-Dex, Inc. (PDEX) is 26.18%

According to Pro-Dex, Inc.’s latest financial reports and current stock price. The company's current ROE is 26.18%. This represents a change of 300.59% compared to the average of 6.54% of the last 4 quarters.

Pro-Dex, Inc. (PDEX) Historical ROE (quarterly & annually)

How has PDEX ROE performed in the past?

The mean historical ROE of Pro-Dex, Inc. over the last ten years is 22.13%. The current 26.18% ROE has changed 18.27% with respect to the historical average. Over the past ten years (40 quarters), PDEX's ROE was at its highest in in the December 2016 quarter at 26.18%. The ROE was at its lowest in in the September 2023 quarter at -1.97%.

Quarterly (TTM)
Annual

Average

22.13%

Median

23.39%

Minimum

6.89%

Maximum

37.08%

Pro-Dex, Inc. (PDEX) ROE by Quarter and Year

Discovering the peaks and valleys of Pro-Dex, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 300.46%

Maximum Annual ROE = 37.08%

Minimum Annual Increase = -74.70%

Minimum Annual ROE = 6.89%

Quarterly (TTM)
Annual
YearROEChange
202628.68%17.03%
202524.51%255.67%
20246.89%-69.23%
202322.39%24.56%
202217.98%0%
202117.98%-43.93%
202032.06%31.47%
201924.39%159.92%
20189.38%-74.70%
201737.08%300.46%

Pro-Dex, Inc. (PDEX) Average ROE

How has PDEX ROE performed in the past?

The current ROE of Pro-Dex, Inc. (PDEX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

20.03%

5-year avg

20.09%

10-year avg

22.13%

Pro-Dex, Inc. (PDEX) ROE vs. Peers

How is PDEX’s ROE compared to its peers?

Pro-Dex, Inc.’s ROE is greater than SkyAI, Inc. (-153.83%), greater than Sera Prognostics, Inc. (-52.54%), greater than Microbot Medical Inc. (-21.87%), greater than Lucid Diagnostics Inc. (-404.34%), greater than Cognition Therapeutics, Inc. (-50.17%), greater than Apyx Medical Corporation (-78.70%), greater than Greenwich LifeSciences, Inc. (-793.76%), less than Tevogen Bio Holdings Inc. (248.50%), greater than Incannex Healthcare Limited (-18.27%), greater than Rapid Micro Biosystems, Inc. (-177.04%),

Build a custom stock screener for Pro-Dex, Inc. (PDEX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pro-Dex, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pro-Dex, Inc. (PDEX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pro-Dex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Pro-Dex, Inc.'s ROE?

How is the ROE calculated for Pro-Dex, Inc. (PDEX)?

What is the highest ROE for Pro-Dex, Inc. (PDEX)?

What is the 3-year average ROE for Pro-Dex, Inc. (PDEX)?

What is the 5-year average ROE for Pro-Dex, Inc. (PDEX)?

How does the current ROE for Pro-Dex, Inc. (PDEX) compare to its historical average?